Update

Last week, the Biden administration launched a fresh student debt relief effort, opening applications for a new income-driven repayment plan, however, some employers are mentioning student debt repayment in job ads.

Even though six drug companies have filed lawsuits to halt the Medicare drug negotiation program, the companies have until Oct. 2 to present data on their drugs to CMS, which will make initial price offers in February.

Pharmaceutical manufacturers - many are attempting to block the federal government's effort to control drug prices - say the high costs support research and development and point out that Americans get new treatments first.

The federal government should impose restrictions on when account holders can take distributions from retirement accounts and provide more time to pay back 401(k) loans, according to fintech IRALOGIX.

Federal regulators say these arrangements "appear designed to" redirect Medicaid dollars away from facilities that treat the poorest patients to those that provide no Medicaid-covered services, according to a new CMS proposal.

KP's physicians would be involved in developing a "platform" to offer Geisinger and other health systems its value-based care expertise, including in design of care models, pharmacy practices, consumer digital engagement.

Since the health care industry has been experiencing labor shortages, the agencies are trying to figure out a way to investigate the "serial mergers" in the initial notification process.

Weeks before the CMS is releasing a list of drugs eligible for price negotiations, the Justice Department filed a motion, contesting the Chamber's move to block the program, claiming the pause would harm the public.